These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 6291398
1. Metastasizing mammary tumors. Spontaneous mammary tumors in asplenic mice heterozygous for athymia. Mitchell JR, Lozzio BB, Machado E, Coulson P, Linton E. Am J Pathol; 1982 Nov; 109(2):249-52. PubMed ID: 6291398 [No Abstract] [Full Text] [Related]
6. Differences in growth and morphology between the spontaneous C3H mammary carcinoma in the mouse and its syngeneic transplants. McCredie JA, Inch WR, Sutherland RM. Cancer; 1971 Mar; 27(3):635-42. PubMed ID: 5549497 [No Abstract] [Full Text] [Related]
7. Tumours of the mammary gland. Squartini F. IARC Sci Publ (1971); 1979 Mar; 23():43-90. PubMed ID: 233006 [No Abstract] [Full Text] [Related]
8. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Heinlein C, Krepulat F, Löhler J, Speidel D, Deppert W, Tolstonog GV. Int J Cancer; 2008 Apr 15; 122(8):1701-9. PubMed ID: 18092324 [Abstract] [Full Text] [Related]
9. Spontaneous interstitial and Sertoli cell tumors of a testis in a C3H mouse. Franks LM. Cancer Res; 1968 Jan 15; 28(1):125-7. PubMed ID: 5635366 [No Abstract] [Full Text] [Related]
13. The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells. Nanni P, De Giovanni C, Nicoletti G, Landuzzi L, Rossi I, Frabetti F, Giovarelli M, Forni G, Cavallo F, Di Carlo E, Musiani P, Lollini PL. Hum Gene Ther; 1998 Jan 20; 9(2):217-24. PubMed ID: 9472781 [Abstract] [Full Text] [Related]
16. Frequent p53 and H-ras mutations in benzene- and ethylene oxide-induced mammary gland carcinomas from B6C3F1 mice. Houle CD, Ton TV, Clayton N, Huff J, Hong HH, Sills RC. Toxicol Pathol; 2006 Jan 20; 34(6):752-62. PubMed ID: 17162533 [Abstract] [Full Text] [Related]
17. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice. Sacco MG, Barbieri O, Piccini D, Noviello E, Zoppé M, Zucchi I, Frattini A, Villa A, Vezzoni P. Gene Ther; 1998 Mar 20; 5(3):388-93. PubMed ID: 9614559 [Abstract] [Full Text] [Related]
18. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability. Guerra FK, Eijan AM, Puricelli L, Alonso DF, Bal de Kier Joffé E, Kornblihgtt AR, Charreau EH, Elizalde PV. Int J Cancer; 1996 Mar 15; 65(6):812-20. PubMed ID: 8631597 [Abstract] [Full Text] [Related]
19. In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background. Nielsen LL, Gurnani M, Catino JJ, Tyler RD. Anticancer Res; 1995 Mar 15; 15(2):385-92. PubMed ID: 7763010 [Abstract] [Full Text] [Related]
20. Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinoma. Farinelle S, Dedecker R, Malonne H, Werry J, Darro F, Kiss R. Anticancer Res; 1999 Mar 15; 19(2A):1171-80. PubMed ID: 10368671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]